T cell recognition as the target for immune intervention in autoimmune disease.
about
The clinical outcome of autoimmune thrombocytopenic purpura patients is related to their T cell immunodeficiency.Regulation of immunity by anti-T-cell antibodies.Increased frequency of in vivo hprt gene-mutated T cells in the peripheral blood of patients with systemic sclerosis.Positive selection of transgenic receptor-bearing thymocytes by Kb antigen is altered by Kb mutations that involve peptide binding.Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.Therapeutic strategies in multiple sclerosis. I. ImmunotherapyHLA polymorphisms and T cells in rheumatoid arthritis.Determinants of the B-cell response against a transgenic autoantigenMyelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling.Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine.Molecular analysis of the helper T cell response in murine interstitial nephritis. T cells recognizing an immunodominant epitope use multiple T cell receptor V beta genes with similarities across CDR3.Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides.Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blockingAutoimmune thyroiditis and targeted anti-T cell immunotherapy in man.Autoimmune thyroiditis: predisposition and pathogenesis.Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection.Mechanism of Graves thyroiditis: implications for concepts and therapy of autoimmunity.Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity.A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental autoimmune encephalomyelitisSpecific antigen vaccination to treat autoimmune disease.Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha productionQuantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis.A role for CD4+ T-cell subsets producing a selective pattern of lymphokines in the pathogenesis of human chronic inflammatory and allergic diseases.A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens.Activation and differentiation requirements of primary T cells in vitroT cell recognition in experimental autoimmune encephalomyelitis: prospects for immune intervention with synthetic peptides.Induction of self-reactive T cells after murine coronavirus infectionTransformation of human T-cell clones by Herpesvirus saimiri: intact antigen recognition by autonomously growing myelin basic protein-specific T cells.Interaction of T lymphocytes with cerebral endothelial cells in vitro.Transgenic mouse lines that are immunologically tolerant and nontolerant to herpes simplex virus glycoprotein DMitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases.Selective manipulation of the human T-cell receptor repertoire expressed by thymocytes in organ cultureAmelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanismsEnzymes as targets for autoantibodies in human autoimmune disease: relevance to pathogenesis?Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy.
P2860
Q33492948-C2B9A747-ECB0-49C0-9AD0-FE53CC46B619Q33558513-C8C0AC87-FCC1-42E6-882B-7051CDC550CAQ33566116-5FDBE793-4BDC-44E3-8859-66E0D6D9C0AFQ33741290-00D0EAEB-27C7-4819-BEDA-FF9C44FBE750Q33760317-2581FE05-FBA8-4C5E-9987-FFE32036DB2FQ33798254-F915CC8E-A528-476D-B79E-FB18A929B6CFQ33805889-C2A2D7D4-2917-4CBA-8F62-A28DD1FFB786Q33814684-793E6235-003B-4486-BC28-D0B218C0EBC2Q33842739-5227EC32-D29A-4B47-B419-00EA774B7680Q33864435-70C3F723-E3B2-4D44-A186-223C66B4E28BQ33904940-02AB4E3E-0997-4B01-8C17-E66341435170Q33992826-814716A8-BED0-40E7-8B9F-7EBED8E2E482Q34106906-93CC8A98-8461-4B5D-902E-B93F6F12779CQ34158991-7747CEBC-8D9A-464A-8E6F-73BBBEB59768Q34183331-264B0951-95D6-41B4-9B9E-EF29D13728B7Q34323651-C064858F-D6D7-4D1F-BF1C-91758F3B3BAEQ34792611-5689D370-20BF-4127-AD20-00E6141C9C3BQ34830749-62B8A334-8A4D-4121-B5A8-A9E3B7799F58Q35315562-B456EB63-D80E-486F-AA90-D96A03B64D14Q35478975-3A66DE8D-BBB1-497A-95D6-DAA428563782Q35612175-5CE02855-24FF-4732-9CFD-93CA2AA29CEEQ35661743-930EEF93-43E7-4B42-AB92-2F2B87306990Q35675262-687D113E-A953-45EB-B9EB-F7D7979E6DCFQ35677102-F3B2C26C-D698-4822-8A49-0F1E6ABEE8F8Q35910024-77263991-FE71-4347-86B8-A702B40EF8CCQ36364188-D29620B6-AC64-4740-9AF8-ED045905BB34Q36437858-2A6050A8-6730-475E-8E86-E69188F6B05CQ36539219-0AC439A5-FCC0-4E24-A12E-12503DB18996Q36562710-23B88F41-2F6C-4C6C-85A2-52F2AE017D9BQ36566049-D08B2CDA-158F-4862-B272-DAC520693EAFQ36676939-7B57F45A-9767-44C0-9097-29EB23192480Q36683691-26602230-5B69-4BC7-8D4A-AB28F7F80166Q36687176-7BF1D0F5-03EC-458D-AE7A-657C36A744A2Q36725418-2832A774-B76A-4050-9A10-C884D85696A2Q36821526-F94FC3E6-BF69-4F9E-8601-3CA396E3593BQ36976323-FF0D1BD6-0BCF-4E61-9F74-7EC790E22E2DQ36999757-4A9D8582-E390-4311-AFEB-A0D926189153Q37415917-9A50F02E-3195-425E-949E-EA0438C13692Q37424696-215F90C8-D6D5-4FC7-86C2-C822970DE536Q37449469-F9BF2A3B-DB5C-4B54-8C48-986429487F2A
P2860
T cell recognition as the target for immune intervention in autoimmune disease.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
T cell recognition as the target for immune intervention in autoimmune disease.
@en
type
label
T cell recognition as the target for immune intervention in autoimmune disease.
@en
prefLabel
T cell recognition as the target for immune intervention in autoimmune disease.
@en
P2093
P1433
P1476
T cell recognition as the target for immune intervention in autoimmune disease.
@en
P2093
Acha-Orbea H
McDevitt HO
Steinman L
P304
P356
10.1016/0092-8674(89)90786-1
P407
P577
1989-06-01T00:00:00Z